Vicenne Reports 30% Revenue Growth, Surpassing 1 Billion Dirhams by Year-End 2025

Strong Q4 Performance

Vicenne's consolidated revenue for the fourth quarter of 2025 reached 389 million dirhams, reflecting a robust 39% increase compared to the same quarter in 2024.

Annual Revenue Milestone

For the entire fiscal year, the company reported total revenues of 1.084 billion dirhams, representing a 30% growth over 2024. This performance slightly exceeded management's expectations, surpassing the Business Plan targets set during the initial public offering by 3.6%.

Segment Contributions

The growth across various segments has been notable. The Equipment segment saw a remarkable 52% increase in Q4, driven by the completion of several key projects.

As of December 31, 2025, the revenue contributions by segment were as follows: Equipment revenue rose by 29% to 651 million dirhams, Implantables & Reagents increased by 35% to 319 million dirhams, and Services recorded a 19% rise to 114 million dirhams.

Strategic Investments

In Q4, capital expenditures totaled 15 million dirhams, primarily allocated to financial assets, including a minority investment in DEEPECHO, a startup specializing in AI-driven ultrasound diagnostics. This investment aligns with Vicenne's strategy to diversify into digital technologies.

Improved Financial Position

The company's net debt situation has significantly improved, thanks to various capital increases. Net debt decreased from 315 million dirhams at the end of Q3 2024 to a positive cash balance of 299 million dirhams by December 31, 2025, reflecting an improvement over the figure reported on September 30, 2025.

Outlook Towards 2030

Vicenne remains optimistic about achieving its 2030 objectives outlined during the IPO, with the fundamentals of its business model reaffirmed and sector dynamics remaining favorable.